Compare companies
Selected: 2 of 5
Key figures side by side
| Measure | Kao Norway AS2025 | Lifeline Pharma Holding AS2025 |
|---|---|---|
| Sector and size | Handel · Medium | Handel |
| Score | 43 rank 14,582 of 22,949 | not ranked |
| Operating revenue | 66 MNOKmedian 93 MNOK | not availablemedian 10 MNOK |
| Operating margin | 4.0%median 3.0% | not availablemedian 3.0% |
| Profit margin | 3.9%median 2.8% | not availablemedian 2.6% |
| Return on assets | 8.2%median 11.6% | −8.1%median 8.7% |
| Equity ratio | 24.8%median 30.0% | 95.7%median 33.5% |
| Debt-to-equity | 3.03median 2.23 | 0.05median 1.52 |
| Current ratio | 1.32median 1.39 | not availablemedian 1.64 |
| Revenue growth | −2.0%median 6.1% | not availablemedian 5.2% |
| Employees (Enhetsregisteret) | 13 | not available |
The median is each company's own comparison group: same sector, financial year and size group. Source: Brønnøysund Register Centre.
Indications based on the latest annual accounts from open data. Not investment or financial advice.
